Heart Tronics Stock

Heart Tronics EV/EBIT

EV/EBIT (Enterprise Value to EBIT) of Heart Tronics (HRTT) as of Aug 17, 2026.

EV/EBIT

-0.00

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Heart Tronics is 2026 -0.00 . EV/EBIT (Enterprise Value to EBIT) of Heart Tronics was 2025 - . It decreases by % lower compared to the previous year.

The Heart Tronics EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2000
0.00 base
Jan 1, 2001
0.00 base
Jan 1, 2002
0.00 base
Jan 1, 2003
0.00 base
Jan 1, 2004
0.00 base
Jan 1, 2005
0.00 base
Jan 1, 2006
0.00 base
Jan 1, 2007
0.00 base
YEARPRICE-TO-EBIT
2007 -
2006 -
2005 -
2004 -
2003 -
2002 -
2001 -
2000 -
Access this data via the Eulerpool API
Get Free API Key

Heart Tronics Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Heart Tronics's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Heart Tronics's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Heart Tronics's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Heart Tronics grows earnings faster than its peers.

Heart Tronics Stock analysis

What does Heart Tronics do? Heart Tronics Inc. is a company specializing in the development of medical devices and technologies aimed at monitoring and treating heart diseases. It was founded in 2000 by Dr. A. Martin Gerdes and is headquartered in Irvine, California. The company's business model is based on the development, production, and sale of life-saving medical devices. They offer a wide range of diagnostic and monitoring devices that help doctors diagnose and treat heart diseases. One of their main focuses is the development of devices for monitoring heart rhythm disorders, including factors like blood pressure, pulse rate, and respiratory rate. They also develop devices for the treatment of heart diseases, such as electrophysiological (EP) ablation devices and implantable cardioverter-defibrillators (ICD). Additionally, they have developed telemedicine products for remote patient monitoring, allowing doctors to monitor and analyze patient data in real time. Overall, Heart Tronics has developed a variety of products that have proven effective in the medical community and are focused on saving lives by helping doctors detect diseases and take preventive measures. The company is well positioned for future growth due to advancements in telemedicine and medical devices. They plan to expand their portfolio to develop even more life-saving technologies in the future. In conclusion, Heart Tronics is a company driven by the clear goal of saving lives. They have established themselves as pioneers in the development of medical devices for the treatment of heart diseases and are committed to continuously developing innovative technologies to improve people's lives. Heart Tronics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Heart Tronics stock

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Heart Tronics since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Heart Tronics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API
Get Free API Key

Valuation — Heart Tronics

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Heart Tronics